EGFR and breast carcinoma: Another study revealed that nuclear translocation of EGFR is regulated by AKT, which is associated with gefitinib resistance in breast cancer cells through enhanced gene expression of the breast cancer-resistant protein (BCRP; also known as ATP-binding cassette subfamily G member 2, ABCG2) [49].